日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of Asprosin and Role of TLR4 as a Biomarker in Endometrial Cancer

Asprosin 的作用及 TLR4 作为子宫内膜癌生物标志物的作用

Karkia, Rebecca; Sisu, Cristina; Saravi, Sayeh; Kyrou, Ioannis; Randeva, Harpal S; Chatterjee, Jayanta; Karteris, Emmanouil

Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer.

癌性蛋白磷酸酶抑制剂 2A (CIP2A) 在卵巢癌中的新兴作用

Filipe Alice, Saravi Sayeh, Mustafov Denis, Panfilov Suzana, Banger Simran, Mousavikivaj Seyedehnajmeh, Braoudaki Maria, Kailasam Senthilkumar, Riazalhosseini Yasser, Sahai Michelle A, Drenos Fotios, Sisu Cristina, Karteris Emmanouil

Asprosin activates multiple placental pathways in vitro: Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways

Asprosin 在体外激活多种胎盘通路:证据表明其可能参与血管生成、脂肪酸代谢以及 mTOR、NOTCH 和 WNT 信号通路

Orton, Sophie; Gharanei, Seley; Kazileviciute, Jovile; Saravi, Sayeh; Patel, Vanlata; Chatterjee, Jayanta; Kyrou, Ioannis; Karteris, Emmanouil; Randeva, Harpal S

Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes.

在患有高级别浆液性卵巢癌的患者中,鉴定出癌症相关循环细胞中的 RAD51 焦点:与治疗结果的关联

Alizzi Zena, Saravi Sayeh, Khalique Saira, McDonald Thirza, Karteris Emmanouil, Hall Marcia

Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)

SARS-CoV-2 细胞嗜性相关的宿主细胞进入介质、COVID-19 的病理生理学以及能够调节这些介质表达的 microRNA 的鉴定(综述)

Katopodis, Periklis; Randeva, Harpal S; Spandidos, Demetrios A; Saravi, Sayeh; Kyrou, Ioannis; Karteris, Emmanouil